COMMUNIQUÉS West-GlobeNewswire

-
IRADIMED CORPORATION to Hold 2018 Third Quarter Financial Results Conference Call on October 30th
16/10/2018 -
ImprimisRx to feature new formulation and poster presentation on MKO Melt® at the upcoming American Academy of Ophthalmology Meeting in Chicago
16/10/2018 -
Emerald Health Therapeutics Files 17 Patent Applications Covering Defined Dose™ Cannabis Products
16/10/2018 -
Managers' transactions
16/10/2018 -
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2018
16/10/2018 -
United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement
16/10/2018 -
PotNetwork Holdings, Inc. Releases PCAOB Fully Audited and Reviewed Financial Statements under its Registration As an SEC Reporting Company
16/10/2018 -
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2018 Financial Results
16/10/2018 -
Transactions in relation to share buyback program
16/10/2018 -
Stina Syrjänen resigns from Biohit Oyj’s Board of Directors
16/10/2018 -
HealthLynked Corp. Announces Release of Its WordPress Online Scheduling Software Application that can Integrate with over 60 Million Websites
16/10/2018 -
RAMSAY GENERALE DE SANTE has received competition clearance for the recommended public offer to the shareholders of Capio
16/10/2018 -
RAMSAY GENERALE DE SANTE a reçu l'autorisation de l'Autorité de la concurrence dans le cadre de l'offre publique d'achat recommandée faite aux actionnaires de Capio
16/10/2018 -
Notice of Extraordinary General Meeting in Immunicum AB (publ)
16/10/2018 -
Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment Bank
16/10/2018 -
Nanobiotix reçoit un versement initial de 16 millions d’euros au titre du prêt accordé par la Banque Européenne d’Investissement
16/10/2018 -
Immunicum AB (publ) Raises SEK 351M in a Directed Issue and a Fully Guaranteed Rights Issue for Continued Clinical Development of Ilixadencel - a New and Innovative Cancer Immunotherapy
16/10/2018 -
Rule 2.9 Announcement
16/10/2018 -
Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx® leadership in spondyloarthritis
16/10/2018
Pages